Enovix Shareholder Second Reminder: Early Warrant Expiration Price Condition
Enovix (Nasdaq: ENVX) announced that its common stock has traded above $10.50 for 14 consecutive trading days since the distribution of warrants. The stock closed at $10.78, with warrants remaining $2.03 in-the-money based on their $8.75 exercise price.
If the stock trades at or above $10.50 for 20 out of 30 trading days, the warrants could expire as early as August 19, 2025. To date, approximately 6.1 million warrants have been exercised, generating about $53.6 million in gross proceeds for Enovix. The company urges remaining warrant holders to take action before expiration, as warrants will become non-tradable and non-exercisable afterward.
Enovix (Nasdaq: ENVX) ha annunciato che il suo titolo ordinario 猫 stato scambiato sopra $10,50 per 14 giorni di contrattazione consecutivi dalla distribuzione delle warrant. Il titolo ha chiuso a $10,78, con le warrant che risultano ancora $2,03 'in-the-money' rispetto al prezzo di esercizio di $8,75.
Se il titolo si manterr脿 a o sopra $10,50 per 20 giorni di negoziazione su 30, le warrant potrebbero scadere gi脿 il 19 agosto 2025. Ad oggi sono state esercitate circa 6,1 milioni di warrant, generando circa $53,6 milioni di proventi lordi per Enovix. La societ脿 invita i titolari rimasti a intervenire prima della scadenza, poich茅 dopo tale data le warrant non saranno pi霉 negoziabili n茅 esercitabili.
Enovix (Nasdaq: ENVX) anunci贸 que su acci贸n ordinaria se ha negociado por encima de $10,50 durante 14 d铆as de negociaci贸n consecutivos desde la distribuci贸n de los warrants. La acci贸n cerr贸 en $10,78, con los warrants todav铆a $2,03 in-the-money respecto a su precio de ejercicio de $8,75.
Si la acci贸n cotiza a o por encima de $10,50 durante 20 de 30 d铆as de negociaci贸n, los warrants podr铆an expirar tan pronto como el 19 de agosto de 2025. Hasta la fecha se han ejercido aproximadamente 6,1 millones de warrants, generando cerca de $53,6 millones en ingresos brutos para Enovix. La compa帽铆a insta a los tenedores restantes a actuar antes del vencimiento, ya que despu茅s de esa fecha los warrants dejar谩n de ser negociables y ejercitables.
Enovix (Nasdaq: ENVX)電� 氤错喌欤缄皜 鞗岆煱韸� 氚半秳 鞚错泟 鞐办啀 14瓯半灅鞚� 霃欖晥 欤茧嫻 $10.50毳� 靸來殞頃� 瓯半灅霅愲嫟瓿� 氚滍憸頄堨姷雼堧嫟. 欤缄皜電� $10.78鞐� 毵堦皭頄堨溂氅�, 鞗岆煱韸鸽姅 頄夓偓臧� $8.75毳� 旮办鞙茧 $2.03鞚� 雮挫灛臧�旃橂ゼ 鞙犾頃橁碃 鞛堨姷雼堧嫟.
欤缄皜臧� 30瓯半灅鞚� 欷� 20鞚� 鞚挫儊 $10.50 鞚挫儊鞚� 鞙犾頃橂┐ 鞗岆煱韸鸽姅 2025雲� 8鞗� 19鞚�鞚� 旮绊暣 臁瓣赴 毵岆霅� 靾� 鞛堨姷雼堧嫟. 順勳灛旯岇 鞎� 610毵� 臧滌潣 鞗岆煱韸戈皜 頄夓偓霅橃柎 Enovix鞐� 鞎� $53.6 million鞚� 齑� 靾橃澋鞚� 鞎堦波欤检棃鞀惦媹雼�. 須岇偓電� 雮晞 鞛堧姅 鞗岆煱韸� 氤挫湢鞛愲摛鞐愱矊 毵岆 鞝勳棎 臁办箻毳� 旆暊 瓴冹潉 齑夑惮頃橂┌, 毵岆 頉勳棎電� 鞗岆煱韸戈皜 雿� 鞚挫儊 瓯半灅霅橁卑雮� 頄夓偓霅� 靾� 鞐嗠嫟瓿� 瓴疥碃頄堨姷雼堧嫟.
Enovix (Nasdaq: ENVX) a annonc茅 que son action ordinaire s'est n茅goci茅e au-dessus de 10,50 $ pendant 14 jours de bourse cons茅cutifs depuis la distribution des warrants. L'action a cl么tur茅 脿 10,78 $, les warrants conservant une valeur intrins猫que de 2,03 $ par rapport 脿 leur prix d'exercice de 8,75 $.
Si l'action se n茅gocie 脿 10,50 $ ou plus pendant 20 des 30 jours de bourse, les warrants pourraient expirer d猫s le 19 ao没t 2025. 脌 ce jour, environ 6,1 millions de warrants ont 茅t茅 exerc茅s, g茅n茅rant pr猫s de 53,6 millions $ de produits bruts pour Enovix. La soci茅t茅 encourage les d茅tenteurs restants 脿 agir avant l'expiration, car les warrants ne seront plus n茅gociables ni exer莽ables par la suite.
Enovix (Nasdaq: ENVX) gab bekannt, dass seine Stammaktie seit der Ausgabe der Warrants 14 aufeinanderfolgende Handelstage 眉ber $10,50 gehandelt wurde. Die Aktie schloss bei $10,78, wobei die Warrants basierend auf einem Aus眉bungspreis von $8,75 noch $2,03 'in the money' sind.
Notiert die Aktie an 20 von 30 Handelstagen bei oder 眉ber $10,50, k枚nnten die Warrants bereits am 19. August 2025 verfallen. Bislang wurden etwa 6,1 Millionen Warrants ausge眉bt, was Enovix rund $53,6 Millionen Bruttoerl枚s eingebracht hat. Das Unternehmen fordert verbleibende Inhaber auf, vor dem Ablauf zu handeln, da die Warrants danach nicht mehr handel- oder aus眉bbar sein werden.
- Generated $53.6 million in gross proceeds from 6.1 million warrant exercises
- Stock price consistently trading above $10.50, indicating strong market performance
- Warrants are $2.03 in-the-money, providing value for holders who exercise
- Short window remaining for warrant holders to exercise before potential early expiration
- Risk of warrants becoming worthless if not exercised before expiration date
Insights
Enovix's warrant early expiration condition is nearing completion, potentially bringing additional capital while limiting future dilution.
Enovix's warrant situation deserves close attention as the company approaches a critical threshold. The warrants are currently $2.03 in-the-money (exercise price of $8.75 vs. current share price of $10.78), making them valuable to holders who can purchase shares below market value. With 14 of the required 20 trading days already above the $10.50 threshold, only 6 more qualifying days are needed to trigger early expiration.
What's particularly noteworthy is that approximately 6.1 million warrants have already been exercised, generating
The early expiration mechanism creates a win-win scenario. For the company, it accelerates capital raising while providing certainty around its capital structure. For existing shareholders, early expiration limits future dilution that would occur if warrants remained outstanding longer. The current warrant conversion represents a controlled form of dilution where the company receives cash proceeds at a predetermined price.
The urgency communicated in this announcement also creates a natural catalyst for additional warrant exercises, as holders face a rapidly closing window to capture the warrants' intrinsic value before they potentially expire worthless. This time pressure likely explains why Enovix is providing these regular updates - to maximize conversion before the potential August 19 expiration date.
Enovix Warrants: 14 of 14 Trading Days Above
FREMONT, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX, ENVXW) (鈥淐ompany鈥� or 鈥淓novix鈥�), a leader in advanced silicon battery technology, today announced that the price of its common stock has exceeded
As a reminder, under the warrant agreement, if our stock trades at or above
Ryan Benton, Chief Financial Officer, stated, 鈥淲e鈥檝e now completed 14 consecutive trading days above
As of August 7, approximately 6.1 million Warrants have been exercised, generating approximately
Mr. Benton continued, 鈥淲e鈥檝e already received meaningful exercise notices from many of our shareholders. Every Warrant exercised supports our strategic priorities while preserving ownership for long-term shareholders. We appreciate those who have already taken action, and with only a few potential trading days remaining, we encourage all remaining holders to make decisions regarding their Warrants in a timely manner.鈥�
At the close of business on the expiration date, the Warrants will no longer be tradable or exercisable. While the Company will make every effort to accommodate exercises submitted in good faith by the expiration date, we encourage all Warrant holders to ensure their Warrants are traded or exercised on a timely basis. Processing procedures and timelines may vary by broker or the institution holding your Warrants, so prompt action is recommended.
Enovix expects to provide further periodic updates, including if and when the Early Expiration Price Condition is met.
Further Information Relating to the Warrants
For more information relating to the exercise mechanics and other terms of the Warrants, please refer to the materials filed by the Company with the Securities and Exchange Commission (the 鈥淪EC鈥�) available at https://www.sec.gov and the information posted on the Company鈥檚 website at https://www.enovix.com/enovix-warrant-dividend.
About Enovix Corporation
Enovix is a leader in advancing lithium-ion battery technology with its proprietary cell architecture designed to deliver higher energy density and improved safety. The Company鈥檚 breakthrough silicon-anode batteries are engineered to power a wide range of devices from wearable electronics and mobile communications to industrial and electric vehicle applications. Enovix鈥檚 technology enables longer battery life and faster charging, supporting the growing global demand for high-performance energy storage. Enovix holds a robust portfolio of issued and pending patents covering its core battery design and manufacturing process.
Enovix is headquartered in Silicon Valley with facilities in India, South Korea and Malaysia. For more information visit聽聽and follow us on聽.
No Offer or Solicitation
This press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The issuance of the Warrants has not been registered under the Securities Act of 1933, as amended (the 鈥淪ecurities Act鈥�), as the distribution of a Warrant for no consideration does not constitute a sale of a security under Section 2(a)(3) of the Securities Act. A Form 8-A registration statement and prospectus supplement describing the terms of the Warrants were filed with the SEC and are available on the SEC鈥檚 website located at https://www.sec.gov. Holders of Warrants should read the prospectus supplement carefully, including the Risk Factors section included and incorporated by reference therein. This press release contains a general summary of the Warrants. Please read the Warrant Agreement filed as an exhibit to the Company鈥檚 Current Report on Form 8-K filed with the SEC on July 21, 2025 as it contains important information about the terms of the Warrants.
Forward鈥怢ooking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, about us, the Warrants and our business that involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and can be identified by words such as anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, should, would and similar expressions that convey uncertainty about future events or outcomes. Forward-looking statements in this press release include, without limitation, our expectations regarding the Early Expiration Price Condition, our ability to accommodate good faith exercises, and the anticipated trading prices of our common stock. Actual results and outcomes could differ materially from these forward-looking statements as a result of certain risks and uncertainties, including, without limitation, those risks and uncertainties and other potential factors set forth in our filings with the SEC, including in the 鈥淩isk Factors鈥� and 鈥淢anagement鈥檚 Discussion and Analysis of Financial Condition and Results of Operations鈥� sections of our most recently filed annual report on Form 10-K and quarterly reports on Form 10-Q and other documents that we have filed, or that we will file, with the SEC. For a full discussion of these risks, please refer to Enovix鈥檚 filings with the SEC, including its most recent Form 10-K and Form 10-Q, available at https://ir.enovix.com and www.sec.gov. Any forward-looking statements made by us in this press release speak only as of the date on which they are made and subsequent events may cause these expectations to change. We disclaim any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise, except as required by law.
Investor Contact:
Robert Lahey
[email protected]
Chief Financial Officer:
Ryan Benton
[email protected]
FAQ
When will the Enovix (ENVX) warrants expire?
How much has Enovix (ENVX) raised from warrant exercises so far?
What is the current exercise price for Enovix (ENVX) warrants?
What happens to unexercised Enovix (ENVX) warrants after the expiration date?
How many consecutive days has Enovix (ENVX) stock traded above $10.50?
